191 related articles for article (PubMed ID: 36810476)
1. Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI.
Palombo M; Valindria V; Singh S; Chiou E; Giganti F; Pye H; Whitaker HC; Atkinson D; Punwani S; Alexander DC; Panagiotaki E
Sci Rep; 2023 Feb; 13(1):2999. PubMed ID: 36810476
[TBL] [Abstract][Full Text] [Related]
2. VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Johnston EW; Bonet-Carne E; Ferizi U; Yvernault B; Pye H; Patel D; Clemente J; Piga W; Heavey S; Sidhu HS; Giganti F; O'Callaghan J; Brizmohun Appayya M; Grey A; Saborowska A; Ourselin S; Hawkes D; Moore CM; Emberton M; Ahmed HU; Whitaker H; Rodriguez-Justo M; Freeman A; Atkinson D; Alexander D; Panagiotaki E; Punwani S
Radiology; 2019 May; 291(2):391-397. PubMed ID: 30938627
[TBL] [Abstract][Full Text] [Related]
3. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.
Panagiotaki E; Chan RW; Dikaios N; Ahmed HU; O'Callaghan J; Freeman A; Atkinson D; Punwani S; Hawkes DJ; Alexander DC
Invest Radiol; 2015 Apr; 50(4):218-27. PubMed ID: 25426656
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in the Diagnosis of Prostate Cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI.
Wichtmann BD; Zöllner FG; Attenberger UI; Schönberg SO
Rofo; 2021 Apr; 193(4):399-409. PubMed ID: 33302312
[TBL] [Abstract][Full Text] [Related]
8. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
9. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
[TBL] [Abstract][Full Text] [Related]
10. Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?
Abd-Alazeez M; Ahmed HU; Arya M; Allen C; Dikaios N; Freeman A; Emberton M; Kirkham A
Urol Oncol; 2014 Aug; 32(6):741-7. PubMed ID: 24981993
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
[TBL] [Abstract][Full Text] [Related]
12. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
[TBL] [Abstract][Full Text] [Related]
13. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
14. Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models.
Sen S; Valindria V; Slator PJ; Pye H; Grey A; Freeman A; Moore C; Whitaker H; Punwani S; Singh S; Panagiotaki E
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885536
[TBL] [Abstract][Full Text] [Related]
15. 3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?
Valerio M; Zini C; Fierro D; Giura F; Colarieti A; Giuliani A; Laghi A; Catalano C; Panebianco V
Eur J Radiol; 2016 Apr; 85(4):790-4. PubMed ID: 26971425
[TBL] [Abstract][Full Text] [Related]
16. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy.
Boesen L; Noergaard N; Chabanova E; Logager V; Balslev I; Mikines K; Thomsen HS
Scand J Urol; 2015 Feb; 49(1):25-34. PubMed ID: 24922550
[TBL] [Abstract][Full Text] [Related]
17. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
[TBL] [Abstract][Full Text] [Related]
18. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
19. Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
Broeke NC; Peterson J; Lee J; Martin PR; Farag A; Gomez JA; Moussa M; Gaed M; Chin J; Pautler SE; Ward A; Bauman G; Bartha R; Scholl TJ
J Magn Reson Imaging; 2019 May; 49(5):1409-1419. PubMed ID: 30430700
[TBL] [Abstract][Full Text] [Related]
20. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
